The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Osteosarcoma Market Research Report 2024

Global Osteosarcoma Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1805423

No of Pages : 89

An osteosarcoma (OS) is a cancerous tumor in a bone. Specifically, it is an aggressive malignant neoplasm that arises from primitive transformed cells of mesenchymal origin (and thus a sarcoma) and that exhibits osteoblastic differentiation and produces malignant osteoid. Osteosarcoma is the most common histological form of primary bone cancer. It is most prevalent in teenagers and young adults.

Global Osteosarcoma market is projected to reach US$ 677.7 million in 2029, increasing from US$ 518.2 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Osteosarcoma market research.

Osteosarcoma is the eighth-most common form of childhood cancer, comprising 2.4% of all malignancies in pediatric patients, and about 20% of all primary bone cancers. Incidence rates for osteosarcoma in U.S. patients under 20 years of age are estimated at 5.0 per million per year in the general population, with a slight variation between individuals of black, Hispanic, and white ethnicities (6.8, 6.5, and 4.6 per million per year, respectively). It is slightly more common in males (5.4 per million per year) than in females (4.0 per million per year).

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Osteosarcoma market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company (Partial List)

  •     Pfizer
  •     Spectrum Pharmaceuticals
  •     Hikma Pharmaceuticals
  •     Baxter
  •     Isofol
  •     Advaxis
  •     Bellicum Pharmaceuticals
  •     Novartis

Segment by Type

  •     Intramedullary Osteosarcoma
  •     Juxtacortical Osteosarcoma
  •     Extraskeletal Osteosarcoma

Segment by Application

  •     Hospital
  •     Clinic
  •     Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

The Osteosarcoma report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Osteosarcoma Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Intramedullary Osteosarcoma
        1.2.3 Juxtacortical Osteosarcoma
        1.2.4 Extraskeletal Osteosarcoma
    1.3 Market by Application
        1.3.1 Global Osteosarcoma Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Osteosarcoma Market Perspective (2018-2029)
    2.2 Osteosarcoma Growth Trends by Region
        2.2.1 Global Osteosarcoma Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Osteosarcoma Historic Market Size by Region (2018-2023)
        2.2.3 Osteosarcoma Forecasted Market Size by Region (2024-2029)
    2.3 Osteosarcoma Market Dynamics
        2.3.1 Osteosarcoma Industry Trends
        2.3.2 Osteosarcoma Market Drivers
        2.3.3 Osteosarcoma Market Challenges
        2.3.4 Osteosarcoma Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Osteosarcoma Players by Revenue
        3.1.1 Global Top Osteosarcoma Players by Revenue (2018-2023)
        3.1.2 Global Osteosarcoma Revenue Market Share by Players (2018-2023)
    3.2 Global Osteosarcoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Osteosarcoma Revenue
    3.4 Global Osteosarcoma Market Concentration Ratio
        3.4.1 Global Osteosarcoma Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Osteosarcoma Revenue in 2022
    3.5 Osteosarcoma Key Players Head office and Area Served
    3.6 Key Players Osteosarcoma Product Solution and Service
    3.7 Date of Enter into Osteosarcoma Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Osteosarcoma Breakdown Data by Type
    4.1 Global Osteosarcoma Historic Market Size by Type (2018-2023)
    4.2 Global Osteosarcoma Forecasted Market Size by Type (2024-2029)

 5 Osteosarcoma Breakdown Data by Application
    5.1 Global Osteosarcoma Historic Market Size by Application (2018-2023)
    5.2 Global Osteosarcoma Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America Osteosarcoma Market Size (2018-2029)
    6.2 North America Osteosarcoma Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Osteosarcoma Market Size by Country (2018-2023)
    6.4 North America Osteosarcoma Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Osteosarcoma Market Size (2018-2029)
    7.2 Europe Osteosarcoma Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Osteosarcoma Market Size by Country (2018-2023)
    7.4 Europe Osteosarcoma Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Osteosarcoma Market Size (2018-2029)
    8.2 Asia-Pacific Osteosarcoma Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Osteosarcoma Market Size by Region (2018-2023)
    8.4 Asia-Pacific Osteosarcoma Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Osteosarcoma Market Size (2018-2029)
    9.2 Latin America Osteosarcoma Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Osteosarcoma Market Size by Country (2018-2023)
    9.4 Latin America Osteosarcoma Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Osteosarcoma Market Size (2018-2029)
    10.2 Middle East & Africa Osteosarcoma Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Osteosarcoma Market Size by Country (2018-2023)
    10.4 Middle East & Africa Osteosarcoma Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Osteosarcoma Introduction
        11.1.4 Pfizer Revenue in Osteosarcoma Business (2018-2023)
        11.1.5 Pfizer Recent Development
    11.2 Spectrum Pharmaceuticals
        11.2.1 Spectrum Pharmaceuticals Company Detail
        11.2.2 Spectrum Pharmaceuticals Business Overview
        11.2.3 Spectrum Pharmaceuticals Osteosarcoma Introduction
        11.2.4 Spectrum Pharmaceuticals Revenue in Osteosarcoma Business (2018-2023)
        11.2.5 Spectrum Pharmaceuticals Recent Development
    11.3 Hikma Pharmaceuticals
        11.3.1 Hikma Pharmaceuticals Company Detail
        11.3.2 Hikma Pharmaceuticals Business Overview
        11.3.3 Hikma Pharmaceuticals Osteosarcoma Introduction
        11.3.4 Hikma Pharmaceuticals Revenue in Osteosarcoma Business (2018-2023)
        11.3.5 Hikma Pharmaceuticals Recent Development
    11.4 Baxter
        11.4.1 Baxter Company Detail
        11.4.2 Baxter Business Overview
        11.4.3 Baxter Osteosarcoma Introduction
        11.4.4 Baxter Revenue in Osteosarcoma Business (2018-2023)
        11.4.5 Baxter Recent Development
    11.5 Isofol
        11.5.1 Isofol Company Detail
        11.5.2 Isofol Business Overview
        11.5.3 Isofol Osteosarcoma Introduction
        11.5.4 Isofol Revenue in Osteosarcoma Business (2018-2023)
        11.5.5 Isofol Recent Development
    11.6 Advaxis
        11.6.1 Advaxis Company Detail
        11.6.2 Advaxis Business Overview
        11.6.3 Advaxis Osteosarcoma Introduction
        11.6.4 Advaxis Revenue in Osteosarcoma Business (2018-2023)
        11.6.5 Advaxis Recent Development
    11.7 Bellicum Pharmaceuticals
        11.7.1 Bellicum Pharmaceuticals Company Detail
        11.7.2 Bellicum Pharmaceuticals Business Overview
        11.7.3 Bellicum Pharmaceuticals Osteosarcoma Introduction
        11.7.4 Bellicum Pharmaceuticals Revenue in Osteosarcoma Business (2018-2023)
        11.7.5 Bellicum Pharmaceuticals Recent Development
    11.8 Novartis
        11.8.1 Novartis Company Detail
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Osteosarcoma Introduction
        11.8.4 Novartis Revenue in Osteosarcoma Business (2018-2023)
        11.8.5 Novartis Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’